046310.KQ Hanall Biopharma Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
10:59
May 21
May 21
Hanall Biopharma clinical success with J&J.
Hanall Biopharma's positive phase results for a rheumatoid arthritis treatment in collaboration with Johnson & Johnson (Janssen) triggered a limit-up and points to significant upside.
HIGH
About 046310.KQ Analyst Coverage
Buzzberg tracks 046310.KQ (Hanall Biopharma) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.